NMDAR2D Antibody

Product Discontinued

NMDAR2D Antibody Summary

• Immunogen: A synthetic peptide from 2d cytoplasmic domain of human NMDAR2D (GRIN2D) conjugated to an immunogenic carrier protein was used as the antigen.
• Specificity: Specific for NMDAR2D.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Rabbit
• Gene: GRIN2D
• Purity: Unpurified

Applications/Dilutions

• Dilutions:
  • Immunohistochemistry 1:10-1:500
  • Immunohistochemistry-Paraffin 1:10-1:500
  • Western Blot 1:300-1:2000
• Application Notes: Immunohistochemistry-Paraffin, Western Blot. A dilution of 1 : 300 to 1 : 2000 is recommended. The optimal dilution should be determined by the end user. Not yet tested in other applications.

Reactivity Notes

Human. Other species not yet tested.

Packaging, Storage & Formulations

• Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
• Buffer: Whole antisera
• Preservative: No Preservative
• Concentration: LYOPH
• Purity: Unpurified
• Reconstitution Instructions: Reconstitute in 100 ul of sterile water. Centrifuge to remove any insoluble material. Glycerol may be added (1:1) for additional stability.

Alternate Names for NMDAR2D Antibody

• EB11
• EB11estrogen receptor binding CpG island
• GluN2D
• glutamate receptor, ionotropic, N-methyl D-aspartate 2D
• GRIN2D
• NMDA epsilon 4
• NMDAR2D
• NMDAR2DN-methyl-d-aspartate receptor subunit 2D
• N-methyl D-aspartate receptor subtype 2D
• NR2D
• NR2Dglutamate [NMDA] receptor subunit epsilon-4

Background

NMDAR2D is an NMDA receptor subtype of glutamate-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. NMDAR2D is mediated by glycine.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: GRIN2D
• Entrez:
  • 2906(Human)